Codexis (CDXS) Amortization of Deferred Charges (2020 - 2026)

Codexis' (CDXS) quarterly Amortization of Deferred Charges came in at $935000.0 in Q1 2026, up 232.74% year-on-year from $281000.0 in Q1 2025, and up 207.1% quarter-over-quarter from -$873000.0 in Q4 2025.

Codexis (CDXS) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends

Codexis' Amortization of Deferred Charges history runs 7 years deep, the most recent figure standing at $935000.0 for Q1 2026.

  • On a quarterly basis, Amortization of Deferred Charges rose 232.74% year-over-year to $935000.0 in Q1 2026; TTM through Mar 2026 was $2.0 million, a 80.72% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 47.46% from the prior year.
  • Amortization of Deferred Charges rose to $935000.0 in Q1 2026 per CDXS's latest filing, from -$873000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $3.6 million in Q3 2023 and bottomed at -$3.6 million in Q4 2023.
  • The 5-year median for Amortization of Deferred Charges is $291000.0 (2025), against an average of $183823.5.
  • Across the five-year window, Amortization of Deferred Charges plunged 523.65% in 2022 and jumped 242.68% in 2025, its largest moves.
  • Year by year, Amortization of Deferred Charges stood at -$3.6 million in 2022, then fell by 0.8% to -$3.6 million in 2023, then surged by 59.45% to -$1.5 million in 2024, then soared by 40.97% to -$873000.0 in 2025, then soared by 207.1% to $935000.0 in 2026.
  • Per Business Quant, the three latest CDXS Amortization of Deferred Charges figures stand at $935000.0 (Q1 2026), -$873000.0 (Q4 2025), and $1.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,861.65 Bn 66,861.36 Bn -
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn -
3 Akari Therapeutics 1,071.19 Bn 1,071.19 Bn -
4 BeOne Medicines 469.11 Bn 464.32 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.03 Bn 115.78 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.13 Bn 61.37 Bn 3.31 Bn
7 Belite Bio 63.44 Bn 63.44 Bn -
8 Argenx Se 55.97 Bn 50.78 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.53 Bn 34.52 Bn 959.66 Mn
10 Codexis 145.68 Mn 80.54 Mn 13.18 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 935,000.00
Mar 31, 2026 935,000.00
Dec 31, 2025 -873,000.00
Dec 31, 2025 -873,000.00
Sep 30, 2025 1.61 Mn
Sep 30, 2025 1.61 Mn
Jun 30, 2025 291,000.00
Jun 30, 2025 291,000.00
Mar 31, 2025 281,000.00
Mar 31, 2025 281,000.00
Dec 31, 2024 -1.48 Mn
Dec 31, 2024 -1.48 Mn
Sep 30, 2024 2.02 Mn
Sep 30, 2024 2.02 Mn
Jun 30, 2024 263,000.00
Jun 30, 2024 263,000.00
Mar 31, 2024 82,000.00
Mar 31, 2024 82,000.00
Dec 31, 2023 -3.65 Mn
Dec 31, 2023 -3.65 Mn